These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34360679)
1. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679 [TBL] [Abstract][Full Text] [Related]
3. Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer. Oto J; Plana E; Fernández-Pardo Á; Cana F; Martínez-Sarmiento M; Vera-Donoso CD; España F; Medina P Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33105660 [TBL] [Abstract][Full Text] [Related]
4. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma. Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891 [TBL] [Abstract][Full Text] [Related]
5. Identification of a four-microRNA panel in serum for screening renal cell carcinoma. Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264 [TBL] [Abstract][Full Text] [Related]
6. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297 [TBL] [Abstract][Full Text] [Related]
7. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients. Bustos MA; Gottlieb J; Choe J; Suyeon R; Lin SY; Allen WM; Krasne DL; Wilson TG; Hoon DSB; Linehan JA Clin Chem; 2024 Jan; 70(1):261-272. PubMed ID: 37791385 [TBL] [Abstract][Full Text] [Related]
10. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma. Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447 [TBL] [Abstract][Full Text] [Related]
11. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013 [TBL] [Abstract][Full Text] [Related]
12. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma. Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Gowrishankar B; Ibragimova I; Zhou Y; Slifker MJ; Devarajan K; Al-Saleem T; Uzzo RG; Cairns P Cancer Biol Ther; 2014 Mar; 15(3):329-41. PubMed ID: 24351440 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-30a-5p Outeiro-Pinho G; Barros-Silva D; Aznar E; Sousa AI; Vieira-Coimbra M; Oliveira J; Gonçalves CS; Costa BM; Junker K; Henrique R; Jerónimo C J Exp Clin Cancer Res; 2020 Jun; 39(1):98. PubMed ID: 32487203 [TBL] [Abstract][Full Text] [Related]
15. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390 [TBL] [Abstract][Full Text] [Related]
16. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p. Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141 [TBL] [Abstract][Full Text] [Related]
17. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma. Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma. Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711 [TBL] [Abstract][Full Text] [Related]
19. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence. Zhang J; Ye Y; Chang DW; Lin SH; Huang M; Tannir NM; Matin S; Karam JA; Wood CG; Chen ZN; Wu X Am J Pathol; 2018 Nov; 188(11):2487-2496. PubMed ID: 30201497 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]